Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Clemons currently holds 1,217,122 shares of CEREBAIN BIOTECH CORP. (DDOOD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Clemons has been a net buyer of DDOOD stock. They have purchased $121.0K and sold $0 worth of shares.
Eric Clemons's most recent insider trade was on Feb 19, 2018, when they sold 160,000 shares at $0.18 per share.
Eric Clemons serves as Executive at CEREBAIN BIOTECH CORP. (DDOOD). They have executed 10 insider transactions totaling $121.0K over their tenure at the company.
Eric Clemons holds the position of Executive at CEREBAIN BIOTECH CORP., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Eric Clemons has shown a buying trading pattern, with $121.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Eric Clemons was on Apr 1, 2015, when they purchased $1.4B worth of CBBT shares. This transaction involved 380,625 shares at $3806.25 per share.
Eric Clemons currently owns 1,217,122 shares of CEREBAIN BIOTECH CORP. (DDOOD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Clemons's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Clemons has 10 Form 4 filings on record as an insider at CEREBAIN BIOTECH CORP..
Set alerts for Eric Clemons and 40,000+ other insiders.